- Home
- ORIC vs ESQ Comparison
ORIC vs ESQ Comparison
Compare ORIC & ESQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ORIC | ESQ |
|---|---|---|
| Founded | 2014 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Commercial Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 837.3M | 941.0M |
| IPO Year | 2020 | 2017 |
Fundamental Metrics
Financial Performance| Metric | ORIC | ESQ |
|---|---|---|
| Price | $8.97 | $108.85 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 3 |
| Target Price | $19.73 | ★ $120.33 |
| AVG Volume (30 Days) | ★ 2.3M | 84.3K |
| Earning Date | 05-04-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 0.73% |
| EPS Growth | ★ 19.67 | 14.20 |
| EPS | N/A | ★ 5.87 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $28.65 |
| Revenue Next Year | N/A | $4.95 |
| P/E Ratio | ★ N/A | $18.60 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.90 | $73.57 |
| 52 Week High | $14.93 | $119.86 |
Technical Indicators
Market Signals| Indicator | ORIC | ESQ |
|---|---|---|
| Relative Strength Index (RSI) | 38.27 | 59.84 |
| Support Level | N/A | $91.62 |
| Resistance Level | $11.19 | $112.17 |
| Average True Range (ATR) | 1.05 | 3.52 |
| MACD | -0.37 | 0.47 |
| Stochastic Oscillator | 30.29 | 68.41 |
Price Performance
Historical ComparisonAbout ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
About ESQ Esquire Financial Holdings Inc.
Esquire Financial Holdings Inc is a financial holding company operating as a full service commercial bank. It serves the financial needs of the litigation industry and small businesses nationally, as well as commercial and retail customers in the New York metropolitan area. The bank offers tailored financial and payment processing solutions to the litigation community and their clients as well as dynamic and flexible payment processing solutions to small business owners. It operates in one operating segment, that of community banking.